ARCA biopharma Inc (NASDAQ:ABIO)

North American company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ABIO

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ABIO

  • Market Cap$37.480m
  • SymbolNASDAQ:ABIO
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS00211Y5069

Company Profile

ARCA biopharma Inc is a biopharmaceutical company. It applies precision medicine approach to develop genetically targeted therapies for cardiovascular diseases. The firm's lead product candidate is Gencaro. The company adopts genotype-directed comparative effectiveness trial of Bucindolol and Toprol-XL for prevention of symptomatic atrial fibrillation in patients with heart failure. It establishes long-term relationships with partners such as Medtronic, Laboratory Corporation of America and the University of Colorado.ARCA biopharma Inc is a biopharmaceutical company. It applies precision medicine approach to develop genetically targeted therapies for cardiovascular diseases.

Latest ABIO news

Currently there for this company. Visit our news hub for other news .